[En pailettes d'or maculopathy caused by carotinoid therapy].
D016644:Canthaxanthin; D002338:Carotenoids / Q000009:adverse effects* / Q000031:analogs & derivatives*; D003460:Crystallization; D004338:Drug Combinations / Q000009:adverse effects; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008266:Macula Lutea / Q000187:drug effects*; D012164:Retinal Diseases / Q000139:chemically induced*; D019207:beta Carotene
D004338:Drug Combinations; D019207:beta Carotene; D002338:Carotenoids; D016644:Canthaxanthin; C041347:phenoro
Zur Maculopathie en paillettes d'or durch Carotinoid-Therapie.